The Corporate Governance Code
The Directors of GW Pharmaceuticals plc recognize the importance of the highest standards as it relates to corporate governance.
The Board of Directors
The GW Board of Directors which is majority-independent currently comprises two Executive and three independent non-executive Directors.
The Board of Directors has overall responsibility for the Group. Its aim is to represent the interests of the Group's shareholders and to provide leadership and control in order to ensure the growth and development of a successful business.
Mr James Noble acts as the Company's Deputy Chairman and senior independent non-executive.
All Directors are able to take independent advice in furtherance of their duties if necessary.
The Board is responsible to shareholders for the proper management of the Group, and Board meetings are held at least six times a year to set the overall direction and strategy of the Group, to review financial and operating performance and to advise on senior management appointments. Financial policy and budgets, including capital expenditure, are approved and monitored by the Board. All key strategic decisions are subject to Board approval. The Company Secretary is responsible for ensuring that Board procedures are followed and that applicable rules and regulations are complied with.
Directors are subject to election by shareholders at the first opportunity after their appointment. In addition, one third of the Directors are subject to retirement by rotation at each Annual General Meeting.
The sub-committees of the GW Board are entirely comprised of independent non-executive Directors.
Committees of the Board
There are three committees of the Board, details of which can be found by clicking on the links below: